Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "copd"

Case studies on drug development and novel targets from Glenmark Pharmaceuticals and Novartis at COPD 2016 3 Aug 2016
Medical News Today

AZ trumpets positive COPD data to help Symbicort stand up to r...

The already crowded COPD field is only going to get more competitive going forward--but AstraZeneca is boasting new data it hopes will keep its player going strong. Last week, the British drugmaker trumpeted top-line results from a study in which ... FiercePharma, 2 weeks ago
Airway Hyperresponsiveness And Copd Outcomes Journal of Allergy and Clinical Immunology, 2 weeks ago
COPD review risky say lung bodies Pharma In Focus, 3 weeks ago

348 images for copd

BioSpace, 1 hour ago
Australian Doctor, 10 hours ago
MyNewsDesk, 3 days ago, 8 hours ago
News Talk 650 CKOM, 2 days ago
Biz Community, 1 week ago
British Journal of the Heart, 5 days ago
MedPage Today, 1 week ago
Mobihealthnews, 1 week ago
Advance for Respiratory Care & Sleep Medicine, 2 weeks ago

The United States Market Survey- Asthma And COPD Drug Sales Market Report 2016

Report Summary The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Asthma And COPD Drug market analysis is provided for the United States markets including ...
 MyNewsDesk2 weeks ago Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis  CHEST2 weeks ago HPRA MIMS Article July 2016 Risk of Pneumonia with Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease (COPD)  HPRA2 weeks ago Global COPD Pricing, Reimbursement, and Access Report 2016 - How do US and European payers and physicians view the launch of once-daily Breo?  4 Traders2 weeks ago

Sunovion Pharmaceuticals Submits New Drug Application For COPD

Source: Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for SUN-101/eFlow®, an investigational treatment for the long-term, maintenance ...
 NEWS-Line for Physician Assistants3 weeks ago Sunovion Submits New Drug Application for SUN-101/eFlow to the FDA for COPD Treatment  Advance for Respiratory Care & Sleep Medicine3 weeks ago Sunovion Pharma seeks US FDA approval for SUN-101/eflow to treat airflow obstruction in patients with COPD  PharmaBiz3 weeks ago Sunovion submits NDA for SUN-101/eFlow to the FDA for COPD  Center Watch4 weeks ago

Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables

- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD ...
 4 Traders2 weeks ago Cannabis Science Inc. Develops Inhalation Medication For Those Suffering Asthma/COPD Via Nebulizer, Targets National Markets  BioSpace4 weeks ago Cannabis Science Seeks Patients to Receive the Free CBIS MDI Rescue Inhaler  BioSpace2 weeks ago Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials  4 Traders2 weeks ago

COPD Drugs Market - 4.85% CAGR Driven by Growing Adoption of Combination Therapies to 2020

PUNE, India , Aug. 5, 2016 /PRNewswire-iReach/ -- The global COPD drugs market analyst says innovative technologies for drug delivery will be one of the key trends for market growth. Vendors are investing heavily in R&D activities to design and ...
 WorldNetDaily3 weeks ago

Lung Institute Hosts New COPD Treatment Seminar in Knoxville, Offering On-Site Consultations

PRWeb The Lung Institute will host a seminar at the University of Tennessee in Knoxville on August 9 to inform people with chronic lung diseases on the benefits of stem cell therapy for lung disease. Jack Coleman, Jr., M.D., will lead the ...
 International Business Times3 weeks ago
American Council On Science & Health

Association of Part D Coverage Gap With COPD Medication Adherence

Using longitudinal Medicare claims data, this study quantified the association of the Medicare Part D coverage gap with medication adherence among beneficiaries with chronic obstructive pulmonary disease. Yanni F. Yu, DSc, MA, MS; Larry R. Hearld, ...
 American Journal of Managed Care4 weeks ago Medicare to Refine and Expand its Value-Based Insurance Design Model  National Law Review2 weeks ago CMS amends value-based model for Medicare Advantage for 2018  HealthImaging2 weeks ago CMS Expands Value-Based Medicare Advantage Model, Allows Telemedicine for Some Conditions  Healthcare Informatics Online2 weeks ago
Physician's Briefing

Considerable health care system burden for undiagnosed COPD

Home » Health » / no comments Based on recent estimates, there are about 32 million cases of rheumatic heart disease (RHD) worldwide, which cause 275,000 deaths per year. Effective drugs and surgical procedures to prevent and treat the ...
 HealthMediciNet.com2 weeks ago Compliance Mentor - August 2016  AHC Media3 weeks ago Marshfield Clinic Health System, Contessa Health Create Partnership To Operate A Home Hospitalization Program  Home Health Provider .com3 weeks ago

Does Telemedicine Work for Diabetic Retinopathy Screening?

Telemedicine has had various outcomes across different medical specialties. For one, results with COPD were found inconclusive and, although physicians seem to like the idea, many don't use it . In a poster presentation at the 34 th Annual ...
 HCPLive2 weeks ago

AstraZeneca Announces Positive Top-Line Data from Two Phase III SYMBICORT Studies

New findings from studies of SYMBICORT in adult patients with COPD and pediatric patients with asthma WILMINGTON, Del.--( EON: Enhanced Online News )--AstraZeneca today announced positive top-line results from two international, multicenter ...
 Enhanced Online News2 weeks ago AstraZeneca PLC Announces Positive Top-Line Data From Two Phase III SYMBICORT Studies  BioSpace2 weeks ago AstraZeneca reports positive top-line results from two trials of symbicort  Drug Development Technology2 weeks ago AstraZeneca announces positive phase III SYMBICORT data  Center Watch2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less